Rephonic
Artwork for JCO Precision Oncology Conversations

JCO Precision Oncology Conversations

American Society of Clinical Oncology (ASCO)
Lung Cancer
Clinical Trials
Lungmap
Liquid Biopsy
Circulating Tumor DNA
Prostate Cancer Genetic Testing
Precision Oncology
Social Demographic Representativeness
Immunotherapy
Cell-Free Dna-Based Multi-Cancer Detection Test
Oncology
Signatera Assay
Breast Cancer
FDA
Next-Gen Sequencing
Squamous Cell Lung Cancer
Biomarker-Driven Therapies
Astrazeneca
Non-Inferiority Trials
Patient-Driven Education

JCO Precision Oncology Conversations is a monthly podcast featuring conversations with authors of clinically relevant and significant articles published in the JCO Precision Oncology journal. JCO Precision Oncology Conversations is hosted by the journal's social media editor, Dr. Abdul Rafeh Naqash.

PublishesTwice monthlyEpisodes60Founded3 years ago
Number of ListenersCategories
MedicineHealth & Fitness

Listen to this Podcast

Artwork for JCO Precision Oncology Conversations

Latest Episodes

In this JCO Precision Oncology Article Insights episode, Natalie DelRocco summarizes "Genomic Risk Classifiers in Localized Prostate Cancer: Precise but Not Standardized" by Góes et al. published on September 10, 2025.

TRANSCRIPT

Natalie DelRocco... more

Authors Drs. Jessica Ross and Alissa Cooper share insights into their JCO PO article, "Clinical and Pathologic Landscapes of Delta-Like Ligand 3 and Seizure-Related Homolog Protein 6 Expression in Neuroendocrine Carcinomas" Host Dr. Rafeh Naqash and ... more

YouTube

In this episode of JCO PO Article Insights, host Dr. Jiasen He summarizes the article, "Somatic Mutation Profiles of Colorectal Cancer by Birth Cohort" by Gilad, et al published October 11, 2025.

TRANSCRIPT

Jiasen He: Hello, and welcome to the ... more

YouTube

JCO PO author Dr. Bryson Katona at the University of Pennsylvania Perelman School of Medicine shares insights into his article, "Areas of Uncertainty in Pancreatic Cancer Surveillance: A Survey Across the International Pancreatic Cancer Early Detecti... more

YouTube

Key Facts

Accepts Guests
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Two Onc Docs
Two Onc DocsSam and Karine
ASCO Daily News
ASCO Daily NewsAmerican Society of Clinical Oncology (ASCO)
Journal of Clinical Oncology (JCO) Podcast
Journal of Clinical Oncology (JCO) PodcastAmerican Society of Clinical Oncology (ASCO)
NEJM This Week
NEJM This WeekNEJM Group
Biotech Hangout
Biotech HangoutDaphne Zohar, Josh Schimmer, Brad Loncar, Tim Opler & more

Recent Guests

Dr. Jessica Ross
Third year medical oncology fellow at the Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Episode: DLL3 and SEZ6 Expression in Neuroendocrine Carcinomas
Dr. Alissa Cooper
Thoracic medical oncologist at the Dana-Farber Cancer Institute and instructor in medicine at Harvard Medical School
Dana-Farber Cancer Institute
Episode: DLL3 and SEZ6 Expression in Neuroendocrine Carcinomas
Dr. Bryson Katona
Director of the Gastrointestinal Cancer Genetics Program and Director of the Lynch Syndrome Program
Penn Medicine's Abramson Cancer Center
Episode: Areas of Uncertainty in Pancreatic Cancer Surveillance
Dr. Asaf Maoz
Medical oncologist at Dana-Farber Cancer Institute, Brigham and Women's Hospital, and faculty at Harvard Medical School
Dana-Farber Cancer Institute
Episode: Lynch Syndrome Mortality in the Immunotherapy Era
Dr. Abhishek Tripathi
Associate Professor in the Department of Medical Oncology and Experimental Therapeutics Research at the City of Hope Comprehensive Cancer Center
City of Hope Comprehensive Cancer Center
Episode: Genomic Profile of Small Cell Bladder, Lung and Urothelial Cancer
Dr. Salvador Jaime-Casas
Postdoctoral Research Fellow and first author of the study discussed
City of Hope Comprehensive Cancer Center
Episode: Genomic Profile of Small Cell Bladder, Lung and Urothelial Cancer
Dr. Alison Schram
Associate Attending Physician and Section Head of Oral Therapeutics with Early Drug Development and Gynecologic Medical Oncology Services
Memorial Sloan Kettering Cancer Center
Episode: BRCA-Altered Uterine Sarcoma Treated with PARP Inhibitors
Dr. Philip Philip
Chair of Hematology and Oncology, Leader of GI and Neuroendocrine Oncology, and Medical Director of the Cancer Clinical Trial and Translational Research Office
Henry Ford Cancer Institute at Wayne State University
Episode: A Position Paper on ctDNA Testing in Clinical Trials
Dr. Dean A. Regier
Director at the Academy of Translational Medicine, associate professor at the School of Population and Public Health, UBC senior scientist at the British Columbia Cancer Research Institute
Academy of Translational Medicine
Episode: Effectiveness and Cost-Effectiveness of Gene Panels in Melanoma

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Talking Points

Recent interactions between the hosts and their guests.

Proteomics Predictor for Immunotherapy Benefit
Q: What has being a mentor meant for you?
Being a mentor has been crucial for Dr. Gandara's career, allowing him to give back to the next generation of oncologists and guide them in their development.
Proteomics Predictor for Immunotherapy Benefit
Q: Can you tell us a little bit about the plasma proteomic aspirin?
The plasma proteomic assay was developed to assess plasma proteins in cancer patients and normal individuals, focusing on those with non-small cell lung cancer.
Transcriptome and ctDNA Associates with Pembrolizumab Benefit
Q: How did you choose the genes to include in your analysis?
The genes were selected based on their association with T-cell activation and the immunosuppressive tumor microenvironment.
Transcriptome and ctDNA Associates with Pembrolizumab Benefit
Q: Can you explain some of the important findings from these data?
We observed that certain immune gene expression signatures correlated with better survival outcomes when combined with ctDNA dynamics.
Transcriptome and ctDNA Associates with Pembrolizumab Benefit
Q: Can you elaborate on using tumor-informed ctDNA?
We aimed to understand changes in ctDNA with treatment and planned to combine it with the RNA-based transcriptome signature.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About JCO Precision Oncology Conversations

What is JCO Precision Oncology Conversations about and what kind of topics does it cover?

This podcast features insightful discussions with authors of significant clinical articles published in a prominent oncology journal, focusing primarily on precision oncology. Episodes cover a range of topics, including the latest advancements in cancer research, treatment methodologies, and the implications of genetic factors in oncological care. Noteworthy themes include innovative therapies, immunotherapy, and personalized medicine approaches, with expert commentary that aims to bridge the gap between research and clinical practice. The conversations are geared towards a medical audience interested in staying updated on current research trends and clinical applications in oncology.

Where can I find podcast stats for JCO Precision Oncology Conversations?

Rephonic provides a wide range of podcast stats for JCO Precision Oncology Conversations. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to JCO Precision Oncology Conversations and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does JCO Precision Oncology Conversations get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for JCO Precision Oncology Conversations, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for JCO Precision Oncology Conversations?

Rephonic provides comprehensive predictive audience data for JCO Precision Oncology Conversations, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does JCO Precision Oncology Conversations have?

To see how many followers or subscribers JCO Precision Oncology Conversations has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to JCO Precision Oncology Conversations?

These podcasts share a similar audience with JCO Precision Oncology Conversations:

1. Two Onc Docs
2. ASCO Daily News
3. Journal of Clinical Oncology (JCO) Podcast
4. NEJM This Week
5. Biotech Hangout

How many episodes of JCO Precision Oncology Conversations are there?

JCO Precision Oncology Conversations launched 3 years ago and published 60 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact JCO Precision Oncology Conversations?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for JCO Precision Oncology Conversations?

Rephonic pulls ratings and reviews for JCO Precision Oncology Conversations from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for JCO Precision Oncology Conversations?

Rephonic provides full transcripts for episodes of JCO Precision Oncology Conversations. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on JCO Precision Oncology Conversations?

Recent guests on JCO Precision Oncology Conversations include:

1. Dr. Jessica Ross
2. Dr. Alissa Cooper
3. Dr. Bryson Katona
4. Dr. Asaf Maoz
5. Dr. Abhishek Tripathi
6. Dr. Salvador Jaime-Casas
7. Dr. Alison Schram
8. Dr. Philip Philip

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days